Welcome to our dedicated page for Celanese SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Celanese's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Celanese's regulatory disclosures and financial reporting.
Celanese Corp Chief Accounting Officer Aaron M. McGilvray reported routine equity award activity in company common stock. On February 15, 2026, he acquired 173 shares at $0.00 per share from the vesting and settlement of performance-based restricted stock units granted in 2023. On the same date, 188 shares at $59.12 per share were withheld to cover taxes on these PRSUs and previously reported time-based restricted stock units, reflecting a tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 10,304.378 common shares and indirectly held 824.5446 shares through a 401(k) plan.
Celanese Corp SVP & CFO Chuck Kyrish reported routine equity compensation activity involving performance-based restricted stock units (PRSUs). He acquired 401 shares of common stock upon PRSU vesting and settlement, then disposed of 179 shares that were withheld to cover taxes, leaving 11,136.476 shares held directly.
Celanese Corp SVP & GC Ashley B. Duffie reported equity award activity involving company common stock. On February 15, 2026, Duffie acquired 618 shares at $0.00 per share through the vesting and settlement of previously granted performance-based restricted stock units under the company’s incentive plan. To cover taxes on this vesting, 183 shares were disposed of at $59.12 per share through share withholding, rather than an open-market sale. After these transactions, Duffie directly held 20,894 common shares and indirectly held 633.396 shares through a 401(k) plan.
Celanese Corporation reported solid 2025 cash-generation despite a weak demand backdrop. The company delivered full-year 2025 adjusted earnings per share of $3.98 and operating EBITDA of $1.9 billion. Free cash flow reached $773 million, more than 50 percent higher than 2024, driven by cost reductions, working capital releases and disciplined spending.
Engineered Materials produced 2025 adjusted EBIT of $720 million and operating EBITDA of $1.2 billion at margins of 13 percent and 22 percent. The Acetyl Chain generated adjusted EBIT of $695 million and operating EBITDA of $947 million, also at 16–22 percent margins. Fourth-quarter 2025 adjusted EPS was $0.67, with free cash flow of $160 million.
Celanese refinanced about $4 billion of debt, cutting 2026–2027 maturities from $4.8 billion to $2.1 billion, and closed the Micromax® divestiture for $492 million in cash. For 2026, the company targets free cash flow of $650–$750 million, $50–$70 million of additional cost savings, and first‑quarter adjusted EPS of $0.70–$0.85, while continuing to prioritize deleveraging.
Celanese Corporation reported a challenging 2025 with a large GAAP loss but solid cash generation. Full-year 2025 U.S. GAAP diluted loss per share was $10.44, while adjusted earnings per share were $3.98. Net sales were $9.5 billion, down 7% from the prior year, driven by lower prices and volumes in key end markets.
The company posted a 2025 operating loss of $786 million, but adjusted EBIT reached $1.15 billion and operating EBITDA was $1.89 billion. Free cash flow was $773 million, helped by cost reductions, lower capital spending, and inventory reductions. A $1.1 billion goodwill impairment in Engineered Materials was a major factor behind the GAAP loss.
In the fourth quarter, Celanese delivered U.S. GAAP diluted earnings per share of $0.23 and adjusted earnings per share of $0.67 on net sales of $2.2 billion, a sequential 9% decline as volumes softened. Management expects first-quarter 2026 adjusted earnings per share of $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million while continuing deleveraging and cost-saving initiatives.
Celanese Corp. (CE) received a Schedule 13G filing showing that Capital Research Global Investors beneficially owns 5,565,556 shares of Celanese common stock, representing 5.1% of the class as of December 31, 2025.
The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Celanese. Capital Research Global Investors reports sole voting and sole dispositive power over all 5,565,556 shares out of 109,504,894 shares believed to be outstanding.
Celanese Corporation director Kathryn Hill reported a routine equity compensation transaction. On January 1, 2026, she converted 1,808.351 shares of phantom stock into 1,808.351 shares of Celanese common stock at a price of $0 per share under the company’s 2008 Deferred Compensation Plan.
After this conversion, she directly held 16,808.48 shares of common stock and 1,140.519 phantom stock units. Each phantom stock unit represents the right to receive one share of common stock, payable in shares as provided by the deferred compensation plan.
Celanese Corporation reported that Director Scott M. Sutton resigned from its Board of Directors effective January 4, 2026. He stepped down because of the expected responsibilities and time commitment required for his new role as Chief Executive Officer of Rayonier Advanced Materials Inc. The company states that his resignation is not due to any disagreement with Celanese regarding its operations, policies, or practices.
The Board acknowledges Mr. Sutton’s numerous contributions during his tenure and extends well wishes for his new position. Celanese also issued a press release on January 6, 2026, to publicly announce his resignation.
Celanese Corporation reports that its wholly owned subsidiary Celanese US Holdings LLC has completed a registered debt offering of $600,000,000 of 7.000% Senior Notes due 2031 and $800,000,000 of 7.375% Senior Notes due 2034.
The notes are senior unsecured obligations of the issuer and are guaranteed on a senior unsecured basis by Celanese Corporation and, initially, certain subsidiary guarantors. Interest will be paid semi-annually in arrears on February 15 and August 15 of each year, beginning on August 15, 2026.
Net proceeds from the offering, together with available cash, will be used to repay borrowings under Celanese’s five-year term loan credit agreement due 2027, to fund previously announced and upsized cash tender offers for approximately $1.2 billion of existing 6.665% notes due 2027 and 6.850% notes due 2028, and for general corporate purposes, which may include repaying other outstanding indebtedness.
Celanese Corporation reported that on December 16, 2025 it issued a press release detailing the early results and increase in size of its previously announced cash tender offers for two series of senior notes. The company is conducting cash tender offers to purchase up to an aggregate principal amount of $946,106,000 of its 6.665% Senior Notes due 2027 and up to $254,000,000 of its 6.850% Senior Notes due 2028. The filing mainly updates investors on the status and enlarged maximum size of these debt repurchase transactions.